SEC Form 4 · accession 0000899243-18-020286
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jigar Raythatha
Officer — See Remarks · Director · 10% Owner
Period of report
Jul 19, 2018
Accepted (ET)
Jul 20, 2018 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.50 | Jul 19, 2018 | A | 306,938 | A | — | Jul 18, 2028 | Common Stock | 306,938 | 306,938 | D |
Explanation of responses
- F1This option was granted on July 19, 2018 and is scheduled to vest in equal quarterly installments through July 19, 2022, subject to continued service.
Remarks
President and Chief Executive Officer